Neural transplantation for treatment of Parkinson's disease. (Q34731427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12110244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Neural transplantation for treatment of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12110244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12110244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

2

Paul R Sanberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12110244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12110244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12110244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12110244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12110244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

674-682

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12110244%20AND%20SRC:MED&resulttype=core&format=json

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Porcine neural xenografts in the immunocompetent rat: immune response following grafting of expanded neural precursor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Xenotransplantation for brain repair: reduction of porcine donor tissue immunogenicity by treatment with anti-Gal antibodies and complement

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiparkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Purification of adrenal chromaffin cells increases antinociceptive efficacy of xenotransplants without immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Kidney cografts enhance fiber outgrowth from ventral mesencephalic grafts to the 6-OHDA-lesioned striatum, and improve behavioral recovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Sertoli cell-enriched fractions in successful islet cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Intrastriatal transplantation of Sertoli cells may improve amphetamine-induced rotation and tyrosine hydroxylase immunoreactivity of the striatum in hemiparkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Role of basic FGF and oxygen in control of proliferation, survival, and neuronal differentiation in carotid body chromaffin cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: long-term primate study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Neural transplantation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Encapsulated neural transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Motor fluctuations and dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Neural transplantation of hNT neurons for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Transplantation of cultured human neuronal cells for patients with stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Efficacy of grafted immortalized dopamine neurons in an animal model of parkinsonism: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Prospects for the clinical application of neural transplantation with the use of conditionally immortalized neuroepithelial stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Dopaminergic neurons protected from degeneration by GDNF gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Neural-targeted gene therapy for rodent and primate hemiparkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Cell therapy and transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Cyclosporine A-induced hyperactivity in rats: is it mediated by immunosuppression, neurotrophism, or both?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Histochemical detection of apoptosis in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Caspase inhibition reduces apoptosis and increases survival of nigral transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Neuroprotection of grafted neurons with a GDNF/caspase inhibitor cocktail

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

Additive Effects of Caspase Inhibitor and Lazaroid on the Survival of Transplanted Rat and Human Embryonic Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902297-3

7 January 2021

10.1016/S1359-6446(02)02297-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12110244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference